Skip to content
Trial Eligibility
Menu

Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy

NCT06653400

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

A randomized double-blind placebo controlled trial comparing the effect of a combined ketorolac and lidocaine paracervical block with a standard lidocaine paracervical block on procedure related pain with office hysteroscopies.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Abnormal Uterine Bleeding
  • Analgesia
  • Paracervical Block

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1
Ages
18 years and older
Sex
Female
Healthy volunteers
Accepted
Sponsor
Icahn School of Medicine at Mount Sinai
Last updated on ClinicalTrials.gov
October 31, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • Mount Sinai · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.